Capital And Product InvestmentA recent equity raise improved the balance sheet and funds research and development, enabling international regulatory work, telehealth rollout, and planned AI features that could expand the service offering.
Regulatory DifferentiationOwlet's position as the only FDA-cleared manufacturer of wearable infant pulse oximeters creates a clear product differentiation that can support premium positioning and stronger relationships with healthcare partners.
Subscription MomentumRapid adoption of the Owlet 360 subscription, surpassing 90,000 subscribers, strengthens recurring revenue visibility and supports higher revenue per customer as the service scales.